HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Applied Therapeutics, Inc. (APLT) Investors to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
January 31, 2022 13:35 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Applied Therapeutics, Inc. (NASDAQ: APLT) investors with significant losses to submit your losses now. The firm is investigating...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Applied Therapeutics, Inc. (APLT) Investors to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
January 18, 2022 14:18 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Applied Therapeutics, Inc. (NASDAQ: APLT) investors with significant losses to submit your losses now. The firm is investigating...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Applied Therapeutics, Inc. (APLT) Investors to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
January 13, 2022 17:56 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Applied Therapeutics, Inc. (NASDAQ: APLT) investors with significant losses to submit your losses now. The firm is...